Rankings
▼
Calendar
▼
TLSA Q4 2003 Earnings Report — Tiziana Life Sciences Ltd Revenue & Financial Results | Market Cap Arena
Tiziana Life Sciences Ltd
TLSA
Q4 2003 Earnings
Reported December 30, 2003
Quarter Comparison
Revenue
Operating Income
EPS (Diluted)
Free Cash Flow
Metric
Q4 2003
Q3 2003
Q4 2002
QoQ Change
YoY Change
Revenue
$0
—
—
—
—
Op. Income
-$1M
—
—
—
—
EPS (Diluted)
$-283.52
—
—
—
—
Free Cash Flow
-$1M
—
—
—
—
marketcaparena.com
Income Statement
Item
Amount
REVENUE
$0
Cost of Revenue
$0
GROSS PROFIT
$0
R&D Expenses
$220.1K
Selling & Marketing
$0
General & Administrative
$0
SG&A Expenses
$0
Other Expenses
$147.2K
Operating Expenses
$367.2K
Cost & Expenses
$367.2K
OPERATING INCOME
-$1M
Interest Income
$6.8K
Interest Expense
$5.4K
Other Income/Expenses
-$5.4K
INCOME BEFORE TAX
-$1M
Income Tax Expense
-$20.3K
Net Income from Continuing Ops
-$1M
Net Income from Discontinued Ops
$0
Other Adjustments
$0
NET INCOME
-$1M
Net Income Deductions
$0
BOTTOM LINE NET INCOME
-$1M
D&A
$21.6K
EBIT
-$1M
EBITDA
-$1M
EPS
-$284
EPS Diluted
-$284
marketcaparena.com
Cash Flow Statement
Item
Amount
Net Income
-$1M
Depreciation & Amortization
$21.6K
Stock-Based Compensation
$0
Deferred Income Tax
$0
Other Non-Cash Items
$500.9K
Change in Working Capital
-$226.8K
OPERATING CASH FLOW
-$1M
Capital Expenditure
-$33.8K
Acquisitions (Net)
$0
Purchases of Investments
-$33.8K
Sales/Maturities of Investments
$0
Other Investing Activities
-$198.5K
NET CASH FROM INVESTING
-$266.0K
Net Debt Issuance
$0
Common Stock Repurchased
$0
Common Dividends Paid
$0
Other Financing Activities
$1M
NET CASH FROM FINANCING
$1M
FREE CASH FLOW
-$1M
Net Change in Cash
-$1M
marketcaparena.com
← Q2 2004
TLSA Overview